1.Bilateral Endophthalmitis as the Initial Presentation of Bacterial Meningitis.
Seong Jae KIM ; Seong Wook SEO ; Jong Moon PARK ; In Young CHUNG
Korean Journal of Ophthalmology 2009;23(4):321-324
To report a case of bilateral endophthalmitis as the initial presentation of bacterial meningitis in a young, immunocompetent Korean patient. A 35-year-old female with a one day history of bilateral swollen eyes, visual disturbance, headache, petechial skin rash, and nausea visited our clinic. She was diagnosed as having endogenous endophthalmitis associated with bacterial meningitis. Intravenous broad spectrum antibiotic therapy was initiated with cefotaxime 3 g and ubacillin 3 g, four times daily. Intravitreal antibiotic (vancomycin 1 mg/0.1 mL and ceftazidime 2 mg/0.1 mL) injections were performed in both eyes. Two weeks post presentation, the best corrected visual acuity in both eyes improved to 0.7, and inflammation of the anterior chamber and vitreous cavity was decreased. We recommend that when endogenous endophthalmitis is suspected along with meningitis, or if it is known to be present, intravitreal and intravenous antibiotics should be promptly administered to preserve vision.
Adult
;
Anti-Bacterial Agents/therapeutic use
;
Diagnosis, Differential
;
Endophthalmitis/diagnosis/drug therapy/*etiology
;
Eye Infections, Bacterial/diagnosis/drug therapy/*etiology
;
Female
;
Follow-Up Studies
;
Humans
;
Meningitis, Bacterial/*complications/diagnosis/drug therapy
;
Ophthalmoscopy
2.Suspected Bacterial Endophthalmitis Following Sustained-release Dexamethasone Intravitreal Implant: A Case Report.
Mucella ARIKAN YORGUN ; Melek MUTLU ; Yasin TOKLU ; Hasan Basri CAKMAK ; Nurullah CAGIL
Korean Journal of Ophthalmology 2014;28(3):275-277
A 58-year-old man admitted to our opthalmology department with the complaint of branch retinal vein occlusion. He was treated with intravitreal Ozurdex in the right eye. Two days after the injection, the patient presented with ocular pain and the visual acuity was hand movement. A diagnosis of endophthalmitis was made. We performed emergent pars plana vitrectomy (PPV) and the implant was removed from the vitreous cavity using a retinal forceps. A combination of vancomycin 1.0 mg and amikacin 0.4 mg was injected intravitreally. However, because of the blurring in the vitreus one week after the procedure, phacoemulsification and a repeat PPV was performed. Five days after the last procedure the signs and symptoms of endophthalmitis were resolved. Our case demonstrated that endophthalmitis could develop after intravitreal implantation of Ozurdex. Surgical removal of the implant and immediate vitrectomy seems to be a useful treatment option in these cases.
Device Removal/methods
;
Dexamethasone/administration & dosage/*adverse effects
;
Diagnosis, Differential
;
Drug Implants/*adverse effects
;
Endophthalmitis/diagnosis/*etiology/surgery
;
Eye Infections, Bacterial/diagnosis/*etiology/surgery
;
Glucocorticoids/administration & dosage/adverse effects
;
Humans
;
Intravitreal Injections/adverse effects
;
Male
;
Middle Aged
;
Retinal Vein Occlusion/diagnosis/*drug therapy
;
Vitrectomy